A positive correlation was observed between the midcycle elevation of estrogen (E) and the level of oxytocin-and estrogen-stimulated neurophysin (ESN), the protein carrier of oxytocin, in the plasma of five of six women. The time of the maximal level of E was associated with a level of oxytocin significantly greater than that in either the early follicular or late luteal phase (P < 0.025). Likewise, the level of ESN at midcycle was greater than the level of ESN in the early follicular or late luteal phase (P < 0.0.1). Other than states of lactation or pregnancy, this is the only described cyclic secretion of oxytocin in humans. Since oxytocin chronologically correlates with a rise in the level of E at midcycle, a role for oxytocin in ovulation may be considered. (J Clin Endocrinol Metab 53: 1229, 1981 O UR LABORATORY has recently described a sensitive and specific RIA for the measurement of oxytocin in human plasma (1, 2). There is strong evidence that oxytocin is associated with human neurophysin I or estrogen-stimulated neurophysin (ESN) and that AVP is associated with human neurophysin II or nicotine-stimulated neurophysin (NSN) (2, 3). The only known pharmacological stimulus for oxytocin secretion and its associated neurophysin in the human is the administration of estrogen (2, 4). Both oxytocin and ESN were elevated in the plasma of normal men and women after the ingestion of estrogen, either acutely or chronically (2, 5). Oxytocin increased as early as 12 h after the ingestion of a single dose of 100 jug estrogen orally, and the elevation was sustained until 36 h. This elevation in the level of oxytocin was not a natural spontaneous fluctuation of oxytocin because levels of oxytocin in plasma measured serially over 4 h showed no fluctuations in the level of oxytocin in either individuals who were ingesting estrogen or those not receiving the hormone.Several investigations support the concept that physiological elevations of estrogen are associated with the elevation of ESN in plasma. For example, an elevation of ESN in plasma has been noted throughout pregnancy from the end of the first trimester (6), presumably related to a coincident increase in the level of estrogen. Levels of ESN in the plasma of patients with cirrhosis with feminization were elevated and were believed to be the result of estrogen excess (7). Most convincingly, in the rhesus monkey, Robinson et al. (8) found a close correlation among the midcycle surge of LH, the midcycle elevation of estrogen, and a midcycle increase in ESN. Similarly, Legros et al. (9) were able to detect an elevation of neurophysin at the time of midcycle in women. In some of the women, the neurophysin remained elevated throughout the luteal phase. To assess oxytocin in plasma at midcycle, a sensitive and specific assay for oxytocin was required. The evidence presented in this report indicates that there is an increase in the level of oxytocin in plasma at midcycle which corresponds chronologically to the peak level of estrogen.
Materials and Methods
Selection of s...